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Summary
Osteonecrosis is a common disorder that may go clinically
unrecognized or may result in the collapse of the architecture
of bone, determining severe anatomic alterations of the in-
volved site. Osteonecrosis is not a specific disease entity, but
rather the result of a number of conditions ultimately leading
to an impairment of blood supply to the bone tissue, although
there is evidence that modifications of bone remodelling activ-
ity and weakening of bone structure with formation of mi-
crofractures are implicated as well. According to the site in-
volved and to the factors promoting its development, the mor-
bid anatomy and histopathology of osteonecrosis show a dif-
ferent appearance. This review discusses the main skeletal
manifestations of osteonecrosis, including subarticular avas-
cular necrosis of the femoral head and of the knee, as well as
osteonecrosis of the jaw.
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Necrosis is the cell death due to an irreversible external in-
jury, which is recognizable microscopically by alterations in
the nucleus (swelling, pyknosis, karyorrhexis, karyolysis) and
in the cytoplasm, which becomes eosinophilic. Osteonecro-
sis, that is the death of bone, is a common disorder that may
go clinically unrecognized, or may result in the collapse of the
architectural bony structure, leading to joint pain, bone de-
struction, and loss of function. Synonyms of osteonecrosis
are avascular necrosis, ischemic necrosis, subchondral avas-
cular necrosis, and aseptic necrosis of bone. The term “asep-
tic necrosis” was first used by the German pathologist Georg
Axhausen, who studied the evolution of bone grafts and de-
scribed the process of repair by which new bone is laid down
on dead bone graft (1).
Osteonecrosis is not a specific disease entity, but rather it is
the final common pathway of several conditions leading to
bone death. This review covers the histopathologic aspects of
the main conditions characterized by osteonecrosis with a dis-
cussion of their pathogenesis.
Histopathology of osteonecrosis
It has long been accepted that the histologic sign indicative of
osteonecrosis is empty osteocytic lacunae, but it is now clear
that artefactual loss of staining of osteocytic nuclei may result
from suboptimal tissue fixation. On the other hand, loss of os-
teocytes is not complete until two to four weeks after the onset
of ischemia, according to studies conducted on both human
material and experimental bone infarction in animals (2-4). This
indicates that the histological recognition of bone death may be
delayed if based on this feature alone, even in properly
processed material. In addition, occasional empty lacunae are
seen in the interstitial lamellae between osteones in the cortical
bone, and their number increases with age, probably as a re-
sult of diminished blood supply. They are patchily distributed
within cortical bone, in contrast to the complete loss of osteo-
cytes observed in severe ischemic episodes (5).
The earliest microscopic signs indicative of bone ischemia are
seen in the marrow spaces, where starting from the second
day there is loss of nuclear staining of marrow cells and large
round and ovoid spaces filled with fat appear (6). The fatty and
haemopoietic marrow becomes then ghosted and the small
vessels show evidence of necrosis (Figure 1); after 15 days the
osteocytic lacunae are empty and the trabecular surface is de-
void of cells. At the border of the necrotic zone there is prolifer-
ation of capillaries accompanied by fibroblasts and foamy histi-
ocytes, which are responsible for the breakdown of necrotic fat-
ty marrow, while dead bone is partly removed by osteoclasts
and substituted by newly formed trabeculae; alternatively wo-
ven bone is laid down on the surface of dead trabeculae.
Phemister coined the term “creeping substitution” to indicate
this slow replacement of aseptic dead bone in contrast with the
massive resorption or sequestration of dead bone associated
with osteomyelitis (7, 8).
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Figure 1 - Osteonecrosis following fracture of the femoral head. There
is diffuse coagulative necrosis of marrow cells and osteocytic lacunae
in bone trabeculae are empty (haematoxylin and eosin, 10x obj.).
Pathogenesis
The aetiological factors of osteonecrosis are known only in
some conditions, like fracture, caisson disease, sickle cell dis-
ease, but less clear in others, like systemic lupus erythemato-
sus, corticosteroid administration, alcoholism; idiopathic forms
are frequent as well.
Osteonecrosis involves more frequently the convex articular sur-
faces because of the smaller diameter of the terminal vessels of
this region and the absence of collateral vascularization. Other
intrinsic factors contributing to the development of osteonecrosis
are the reduced vascularity of fat marrow in comparison with
haemopoietic marrow and the non-extensive quality of bone tis-
sue. Impairment of the blood flow may be caused by vascular
compression (external pressure), trauma or occlusion of the ves-
sels by nitrogen bubbles (in caisson disease) or rigid sickle cells
(in sickle-cell anaemia). The mechanism of ischemia and necro-
sis in other non-traumatic osteonecrosis is not clear and several
possible mechanisms have been proposed. Most authors think
that bone necrosis results from primitive vascular problems, in-
cluding vessel infarction, stenosing arteritis, arterio-sclerotic dis-
ease, extraosseous arterial involvement or extraosseous venous
abnormality, or hypercoagulability and hypofibrinolysis. Howev-
er, there is little histological evidence of vascular thrombosis, as
there is little evidence of alterations in the coagulation mecha-
nisms to support these theories.
Frost has been the first to report the almost constant presence
of trabecular microcracks in aseptic bone necrosis, with the
possible exception of necrosis associated with work in com-
pressed air, as the result of failure of healing of this microdam-
age with resultant fatigue fracture (9). Diminished resistance of
the affected bone is thought to determine secondary vascular
impairment at the capillary level either through compression
from relatively inelastic fat cells or through the rupture of small
intratrabecular vessels. Interestingly, evaluation of transiliac
bone-biopsy specimens from patients with aseptic osteonecro-
sis and normal kidney function revealed a marked reduction in
osteoblastic appositional rate and in bone-formation rate at the
cell and tissue level, indicating that non-apparent metabolic
disturbances are present in these patients (10). Alterations in
the remodelling of bone tissue may contribute to the develop-
ment of osteonecrosis in several ways, for example by inducing
a healing defect of microfractures and thus facilitating subchon-
dral fractures ultimately leading to osteonecrosis (10).
Clinico-pathologic presentations
Regardless the aetiology and pathogenesis, bone necrosis re-
sults in different clinico-pathologic presentations related to the
involved site. Infarcts occurring in the shaft of long bones are
likely to be asymptomatic and are usually incidental findings on
X-ray films, in which case they need to be differentiated from
cartilaginous tumours. Clinically manifesting bone infarcts are
usually seen adjacent to a joint, particularly in the femoral head
(11), followed in frequency by the humeral head (12), the knee
(13), the small bones of the hand and the foot (14-17), and the
vertebrae (18). Many of these conditions, especially the idio-
pathic osteonecrosis occurring in childhood or adolescence,
have historical names. Finally, in recent years a peculiar type
of osteonecrosis of the jaws has emerged as a complication of
the use of bisphosphonate drugs.
Osteonecrosis of the femoral head
According to the experience of the Hospital for Special Surgery
(New York), 20% of the femoral head resection for non-trau-
matic causes are performed for subchondral avascular necro-
sis; about 60% of idiopathic cases are bilateral and the majority
of these patients have been treated with corticosteroids or are
alcoholists (19). The median age of patients treated for subar-
ticular avascular necrosis is 54 years while that of patients
treated for ostearthritis is 67. In a review of the experience of
the Hospital for Joint Diseases (New York), from approximately
2000 total hip replacement carried out between 1984 and
1989, the presence of osteonecrosis was identified in 345 pa-
tients (377 specimens, 18.9%) (20).
Before 1960, osteonecrosis of the femoral head in absence of
fracture of the femoral neck was considered an unusual
event. In 1962, Mankin and Brower reviewed the literature
and could find only 27 reported cases, while nowadays this
condition is recognized as an important cause of osteoarthri-
tis (21). Most patients are males, 30 to 60 years old, and
there is often history of corticosteroid treatment or alcoholism.
The reported incidence of bilateral involvement is between
50% and 70% (21).
In addition, osteonecrosis is observed as a secondary compli-
cation of osteoarthrosis of the hip in about 10% of femoral
head removed for joint replacement (22, 23). Secondary os-
teonecrosis appears more frequently as a superficial “shallow”
lesion involving 2-3 mm in depth beneath the articular surface
(36.5% of cases), while less frequently the lesion is larger and
shows a wedge shape similar to that of primary subarticular
avascular necrosis (23). The first type is probably a result of
bone eburnation of osteoarthrosis, which interferes with blood
flow, while the second type appears to be an independent
event presumably caused by similar causal factors involved in
primary osteonecrosis (22, 23).
A fracture of the femoral neck is always followed by ischemic
necrosis of the femoral head, due to the interruption of the
blood supply. These fractures are occasionally seen in the
young age following major trauma, but they are more common
in the osteoporotic or osteomalacic bones of the elderly women
after very minor trauma. Following the process of fracture re-
pairing, or starting from the viable subfoveolar bone, the in-
farcted femoral head undergoes revascularization and repara-
tive processes take place. This is sometimes followed by a col-
lapse of the femoral head, a complication that usually occurs
after a 1.5-2 year period from the fracture of the femoral neck,
and that leads to late secondary changes (24-26).
Catto has described the morphologic modifications associated
with osteonecrosis of the femoral head due to sub-capital frac-
ture, which according to her papers occur four different steps,
but this description can applied to other forms of osteonecrosis
as well. In the first stage there is necrosis of the bone marrow,
without evidence of reparative processes; in the second stage
the reparative processes become evident at the periphery of
the necrotic region; in the third stage there is collapse of the ar-
ticular surface; and in the fourth stage there is evidence of sec-
ondary osteoarthritis (27, 28). These classical anatomical de-
scriptions form the basis of the classification schemes for stag-
ing of osteonecrosis developed for imaging techniques:
– Stage I. At external examination the shape of the femoral
head is unaltered, but on frontal section there is a wedge
shaped subarticular area of necrosis in which the marrow is
yellow-opaque. The infarct is well delimited from the surround-
ing bone by a thin hyperaemic border. Histologically, the articu-
lar cartilage is viable, while the marrow elements of the subar-
ticular bone are substituted by granular eosinophilic material
and ghosts of necrotic adipocytes can be identified. The tra-
becular bone shows empty osteocytic lacunae and at the mar-
gin of the infarct there is increased osteoblastic and osteoclas-
tic activity, accompanied by a proliferation of capillaries and fi-
broblasts in the marrow spaces, which correspond to the hy-
peraemic rim seen macroscopically;
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– Stage II. As in stage I, the articular surface is unaltered, but
due to the progression of reparative processes, the infarcted
area appears better demarcated on section (Figure 2), and a
peripheral rim of sclerosis is visible radiologically. The prolifer-
ating capillaries and fibroblasts extend into the necrotic area,
and dead bone trabeculae are removed by osteoclasts and
substituted by viable new ones, laid down by osteoblasts, re-
sulting in the sclerotic rim;
– Stage III. At this stage there is an evident modification of the
shape of the articular surface due to the collapse of the necrot-
ic bone. On frontal section, there is a linear fracture usually lo-
cated just below the articular cartilage, at the bony end plate
level, or less frequently within the necrotic area or at its periph-
ery (Figure 3). Histologically, the fracture area shows an ad-
mixture of fragmented bony trabeculae and cartilage with
reparative tissues, including reactive woven bone, cartilage
and granulation tissue, that is the appearance of unstable frac-
ture elsewhere in the skeleton. Focal necrosis of the repair tis-
sue around the area of fracture-collapse may occur and it
should not be interpreted as recurrent osteonecrosis, since it is
likely not related to a recurrent ischemic event but rather to the
injury resulting from the fracture itself (29);
– Stage IV. At this stage the shape of the femoral head is se-
verely deformed, due to the progressive detachment of bone
and cartilage fragments from the infracted area (Figure 4).
Bony and cartilaginous debris can be seen in the capsular and
synovial tissues. This is accompanied by the development of
signs of osteoarthritis, including eburnation of bone around the
infarct. When osteoarthritic changes are fully developed, it may
not be possible to recognize the initial cause as that of subar-
ticular avascular necrosis.
Osteonecrosis of the knee 
Spontaneous osteonecrosis of the knee was described as a
distinct entity in 1968 (30). The typical clinical presentation is in
elderly women, often obese and showing osteoporosis, who
complain of sudden onset of pain in the knee, almost always of
the medial condyle of the femur and associated with localized
tenderness at the joint line. There is no history of systemic dis-
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Figure 3 - A – Scanning view of a frontal section of an infarcted femoral
head stained with haematoxylin and eosin. A subchondral fracture is pre-
sent at the periphery of the infarcted area, which has caused the collapse
of the articular surface. The trabeculae in viable bone adjacent to the in-
farct are thickened. B – Specimen radiograph of the same frontal section
in A, showing the fracture line and the rim of bone sclerosis at the periph-
ery of the infarct.
A
B
Figure 2 - Frontal section of a femoral head showing a wedge-shaped
subarticular area of necrosis, which is well separated from the viable
bone by a rim of granulation tissue. The convex shape of the femoral
head is maintained.
Figure 4 - Frontal section of a femoral head showing severe deformity
due to the progressive detachment of bone and cartilage fragments
from the infarcted area.
eases or administration of corticosteroid drugs (13). The lesion
often involves only a small subchondral portion of bone, prefer-
entially of the medial femoral condyle, and in most cases there
is pathological fracture with collapse and fragmentation of the
necrotic segment leading to marked deformities (31). Interest-
ingly, a histopathological analysis of fourteen cases of os-
teonecrosis of the knee revealed the presence of subchondral
insufficiency fracture in most specimens, suggesting that the
primary event leading to spontaneous osteonecrosis of the
knee is a subchondral insufficiency fracture due to osteoporo-
sis or other metabolic diseases (32).
Osteonecrosis of the jaw
Osteonecrosis of the jaw presents mainly in two clinical set-
tings, either as a complication of the treatment with bisphos-
phonate drugs, or following radiotherapy for head and neck
carcinoma, as osteoradionecrosis.
Osteonecrosis of the jaw is a well recognized complication of
the use of bisphosphonates in the treatment of cancer-related
hypercalcemia, as well as in bone involvement by multiple
mieloma and metastatic carcinomas. It was first reported in
2003 (33) and can be defined as the unexpected development
of necrotic bone in the oral cavity of a patient receiving bispho-
sphonate treatment and who has not received radiotherapy to
the head and neck. It may develop spontaneously, but usually
appears after dental surgery procedures, heals poorly or does
not heal over a period of 6 to 8 weeks (34). Most of the report-
ed case (95%) have been associated with pamidronate or zole-
dronic acid given intravenously to control metastatic bone dis-
ease (35).
A recent survey of 1203 oncology patients (904 multiple
myeloma and 229 breast cancer patients) reported that 6,9%
of multiple myeloma patients and 4,3% of breast cancer pa-
tients developed osteonecrosis of the jaw (36). The most
common malignancies associated with osteonecrosis of the
jaw are multiple myeloma and breast cancer, followed by
prostate cancer, lung cancer, uterine leiomyosarcoma, plas-
mocytoma and leukemya (36). The most important predispos-
ing factors for development of osteonecrosis are the type of
bisphosphonate, the total dose, the time of exposure to the
treatment, dental surgery and dental infection. The hazard of
developing osteonecrosis was significantly higher in zole-
dronic acid treatment: 1% within the first year increasing to
21% at three years. Patients who developed osteonecrosis
received a median number of 35 infusions (range 13 to 68)
and median time of exposure to bisphosphonates was 39.3
months (range 11 to 86) (36).
The role of bisphosphonates in the development of os-
teonecrosis of the jaw has not yet been fully understood.
These drugs interfere with bone resorption by inhibiting os-
teoclastic activity, through selective concentration at the inter-
face of the active osteoclast and the bone resorption surface.
Osteoclast activation is the first event of the remodelling
process, which is followed by resorption and formation. This
cycle is critical to maintain bone viability. If osteoclastic func-
tion is too severely impaired and the remodelling process
does not take place, this may predispose to the development
of osteonecrosis of bone. In addition, bisphosphonates have
anti-angiogenic properties which may contribute to the devel-
opment of osteonecrosis (37, 38). Another hypothesis that
has been proposed is based on the fact that teeth are readily
infected by bacteria (come from outside or contained in sali-
va) that cause caries and periodontal disease. Because the
teeth are separated from bone by no more than two millime-
tres of periodontal connective tissue, such infections have
easy access to the underlying bone (39). Why the effect of
bisphosphonates on jaw bones would be different to other
bones is unclear. Bisphosphonates may be highly concentrat-
ed in the jaws because these bones have a greater blood
supply than other bones and a faster turnover rate related
both to their daily activity and the presence of teeth. Coupled
with chronic invasive dental diseases and treatments and the
thin mucosa over bone, this anatomic concentration of bis-
phosphonates causes this condition to be manifested exclu-
sively in the jaws (40).
In our experience, biopsy material from affected areas shows
partially or completely necrotic bone, with empty osteocytic
lacunae and heavily eroded surfaces (Figure 5). A severe
acute and chronic inflammatory infiltrate is present in the in-
ter-trabecular spaces of the surrounding bone tissue, with
neutrophils, eosinophils, plasma cells and histiocytes. Promi-
nent osteoclastic and osteoblastic activity can be seen at the
trabecular surface (Figure 5). In the necrotic area, Actino-
myces colonies are identified in most cases (Figure 6). There-
fore, the overall picture is that of an osteomyelitic process
and it is debated whether there is superinfection of a primarily
necrotic bone by the oral flora or bone necrosis is rather a
consequence of microbial infiltration of metabolically inactive
and poorly vascularized bone. The observation that bone tis-
sue within and adjacent to the affected area is not entirely
necrotic speaks against a bisphosphonate-induced necrosis,
but rather supports the theory that the process is started by
injury and infection, and the reduced remodeling ability due to
bisphosphonate treatment hinders the subsequent reparative
process.
Osteoradionecrosis can be defined as a chronic effect of ra-
diotherapy which progresses slowly and does not tend to heal
spontaneously. In a study by Reuther et al. osteoradionecro-
sis had an incidence of 8.2%, i.e. 68 (62 males and 6 fe-
males) out of 830 patients who received radiotherapy (41).
Sader et al. demonstrated a positive correlation between the
incidence of osteonecrosis and the therapeutic intensity (42).
Osteoradionecrosis was more common in patients treated
with combined radio/chemotherapy before surgery, with the
time range between treatment and development of osteora-
dionecrosis being 9 months for the combination radio/
chemotherapy and 14 months for radiotherapy alone (42). In
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Figure 5 - Bisphosphonate induced osteonecrosis of the jaw. Haema-
toxylin and eosin stained section showing partially necrotic bone trabec-
ulae, with lacunae containing viable osteocytes, necrotic osteocytes or
showing empty lacunae. A severe inflammatory infiltrate is present in
the inter-trabecular spaces (20x obj.).
addition the extent of osteoradionecrosis shows a direct cor-
relation with the radiation dose. Other risk factors are tumor
stage, tumor infiltration of adjacent bone and tooth extraction
(42).
The histological features of osteoradionecrosis of the
mandible are similar to those of bisphosphonate induced os-
teonecrosis of the jaw. It has been hypothesized that osteora-
dionecrosis develops as a consequence of hypoxia due to re-
duced vascularity and radiation-induced endoarteritis. This
may then lead to an infection of the previously weakened
bone and tissues and to the development of a chronic non-
healing wound.
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